메뉴 건너뛰기




Volumn 345, Issue 3, 2001, Pages 170-174

The treatment of multidrug-resistant tuberculosis in Turkey

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; KANAMYCIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; STREPTOMYCIN;

EID: 0035913231     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200107193450303     Document Type: Article
Times cited : (236)

References (12)
  • 1
    • 0028116173 scopus 로고
    • Drug-resistant tuberculosis: Issues in epidemiology and challenges for public health
    • (1994) Tuber Lung Dis , vol.75 , pp. 321-323
    • Rieder, H.L.1
  • 5
    • 4243609734 scopus 로고    scopus 로고
    • Protocol for the implementation of individualized treatment regimens for multidrug resistant tuberculosis in resource-poor settings
    • Espinal MA, ed. Multidrug resistant tuberculosis (MDR TB): basis for the development of an evidence-based case-management strategy for MDR TB within the WHO's DOTS strategy. Geneva: World Health Organization: Part V. (Report no. WHO/TB/99.260.
    • (1999)
    • Farmer, P.1    Kim, J.Y.2    Mitnick, C.D.3    Becerra, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.